Debiopharm Group
About:
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug.
Website: http://www.debiopharm.com/
Twitter/X: DebiopharmHR
Top Investors: CARB-X
Description:
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.
Total Funding Amount:
$4.7M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Lausanne, Vaud, Switzerland
Founded Date:
1979-01-01
Founders:
Rolland-Yves Mauvernay
Number of Employees:
251-500
Last Funding Date:
2021-10-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai